Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Madersbacher

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Current Medical Research and Opinion|December 13, 2007
Safety of prolonged sacral neuromodulation tined lead testingThomas M Kessler, Fiona C Burkhard, Helmut Madersbacher, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 20, 2020
Efficacy and safety of mirabegron for the treatment of low compliance bladder resulting from sacral/infrasacral lesions: A prospective studyPawan Vasudeva, Siddharth Yadav, Helmut Madersbacher, et al.
Medical Devices (Auckland, N.Z.)|October 16, 2018
Gains in health utility associated with urinary catheter innovationsAndrei Krassioukov, Yasuhiko Igawa, Márcio Augusto Averbeck, et al.
BJU International|January 22, 2009
Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomesSaladin Helmut Alloussi, Gerd Mürtz, Silvia Gitzhofer, et al.
Neurourology and Urodynamics|January 16, 2025
Effect of Intrathecal Baclofen on Bladder Function in Patients With Severe Supraspinal SpasticityMarkus Kofler, Lucas-Michael Halbmayer, Gusztav Kiss, et al.
Neurourology and Urodynamics|March 16, 2012
What are the causes and consequences of bladder overdistension? ICI-RS 2011Helmut Madersbacher, Linda Cardozo, Christopher Chapple, et al.
BJU International|November 15, 2008
Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort studyHelmut Madersbacher, Gerd Mürtz, Schahnaz Alloussi, et al.
European Urology|March 26, 2004
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivityAndré Reitz, Manfred Stöhrer, Guus Kramer, et al.
BJU International|April 19, 2016
Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladderJing Leng, Limin Liao, Ben Wan, et al.
Neurourology and Urodynamics|June 23, 2017
Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013Nikki Cotterill, Helmut Madersbacher, Jean J Wyndaele, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Current Medical Research and Opinion|December 13, 2007
Safety of prolonged sacral neuromodulation tined lead testingThomas M Kessler, Fiona C Burkhard, Helmut Madersbacher, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 20, 2020
Efficacy and safety of mirabegron for the treatment of low compliance bladder resulting from sacral/infrasacral lesions: A prospective studyPawan Vasudeva, Siddharth Yadav, Helmut Madersbacher, et al.
Medical Devices (Auckland, N.Z.)|October 16, 2018
Gains in health utility associated with urinary catheter innovationsAndrei Krassioukov, Yasuhiko Igawa, Márcio Augusto Averbeck, et al.
BJU International|January 22, 2009
Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomesSaladin Helmut Alloussi, Gerd Mürtz, Silvia Gitzhofer, et al.
Neurourology and Urodynamics|January 16, 2025
Effect of Intrathecal Baclofen on Bladder Function in Patients With Severe Supraspinal SpasticityMarkus Kofler, Lucas-Michael Halbmayer, Gusztav Kiss, et al.
Neurourology and Urodynamics|March 16, 2012
What are the causes and consequences of bladder overdistension? ICI-RS 2011Helmut Madersbacher, Linda Cardozo, Christopher Chapple, et al.
BJU International|November 15, 2008
Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort studyHelmut Madersbacher, Gerd Mürtz, Schahnaz Alloussi, et al.
European Urology|March 26, 2004
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivityAndré Reitz, Manfred Stöhrer, Guus Kramer, et al.
BJU International|April 19, 2016
Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladderJing Leng, Limin Liao, Ben Wan, et al.
Neurourology and Urodynamics|June 23, 2017
Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013Nikki Cotterill, Helmut Madersbacher, Jean J Wyndaele, et al.
Pageof 5